TY - JOUR
T1 - Anaerobic membrane bioreactors for pharmaceutical-laden wastewater treatment
T2 - A critical review
AU - Oberoi, Akashdeep Singh
AU - Surendra, K.C.
AU - Wu, Di
AU - Lu, Hui
AU - Wong, Jonathan W.C.
AU - Khanal, Samir Kumar
N1 - Publisher Copyright:
© 2022 Elsevier Ltd.
PY - 2022/10
Y1 - 2022/10
N2 - Pharmaceuticals are a diverse group of chemical compounds widely used for prevention and treatment of infectious diseases in both humans and animals. Pharmaceuticals, either in their original or metabolite form, find way into the wastewater treatment plants (WWTPs) from different sources. Recently, anaerobic membrane bioreactors (AnMBR) has received significant research attention for the treatment of pharmaceuticals in various wastewater streams. This review critically examines the behaviour and removal of a wide array of pharmaceuticals in AnMBR with primary focus on their removal efficiencies and mechanisms, critical influencing factors, and the microbial community structures. Subsequently, the inhibitory effects of pharmaceuticals on the performance of AnMBR and membrane fouling are critically discussed. Furthermore, the imperative role of membrane biofouling layer and its components in pharmaceuticals removal is highlighted. Finally, recent advancements in AnMBR configurations for membrane fouling control and enhanced pharmaceuticals removal are systemically discussed.
AB - Pharmaceuticals are a diverse group of chemical compounds widely used for prevention and treatment of infectious diseases in both humans and animals. Pharmaceuticals, either in their original or metabolite form, find way into the wastewater treatment plants (WWTPs) from different sources. Recently, anaerobic membrane bioreactors (AnMBR) has received significant research attention for the treatment of pharmaceuticals in various wastewater streams. This review critically examines the behaviour and removal of a wide array of pharmaceuticals in AnMBR with primary focus on their removal efficiencies and mechanisms, critical influencing factors, and the microbial community structures. Subsequently, the inhibitory effects of pharmaceuticals on the performance of AnMBR and membrane fouling are critically discussed. Furthermore, the imperative role of membrane biofouling layer and its components in pharmaceuticals removal is highlighted. Finally, recent advancements in AnMBR configurations for membrane fouling control and enhanced pharmaceuticals removal are systemically discussed.
KW - Anaerobic membrane bioreactor
KW - Biological wastewater treatment
KW - Biotransformation
KW - Membrane fouling
KW - Pharmaceuticals
UR - http://www.scopus.com/inward/record.url?scp=85135299519&partnerID=8YFLogxK
U2 - 10.1016/j.biortech.2022.127667
DO - 10.1016/j.biortech.2022.127667
M3 - Review article
C2 - 35878778
AN - SCOPUS:85135299519
SN - 0960-8524
VL - 361
JO - Bioresource Technology
JF - Bioresource Technology
M1 - 127667
ER -
